A new publication aims to clarify the Infectious Diseases Society of America’s (IDSA) position regarding antibiotic administration timing in sepsis. It separates hospital-specific strategies from general clinical guidance.
The research, published in the Journal of Clinical Infectious Diseases on November 18, 2026, addresses the long-standing debate over the optimal window for starting antimicrobial therapy in patients with life-threatening infections. It shows how institutional protocols differ from nationwide recommendations.
The research carries the title “Clarifying IDSA's Position on Antibiotic Timing in Sepsis: Distinguishing Hospital Strategies from Clinical Guidance.” It was authored by Chanu Rhee, Michael Klompas, Henry Masur, and Sara E Cosgrove.
The authors hold affiliations with major institutions. These include Harvard Medical School / Harvard Pilgrim Health Care Institute, Brigham and Women’s Hospital, the Clinical Center at the National Institutes of Health, and Johns Hopkins University School of Medicine.
The publication addresses the practical work of sepsis management. Sepsis is a condition defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection. Prompt intervention is considered vital. Sepsis can lead to multiorgan failure and shock, which is often fatal.
Current clinical standards require immediate action when sepsis is recognized.
The Surviving Sepsis Campaign’s international guidelines, published in Critical Care Medicine on April 1, 2026, recommend that patients with sepsis and septic shock receive antibiotics within 1 hour of emergency department triage.
The medical community also relies on established criteria for defining and screening sepsis. Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection, according to the JAMA 2016 consensus definitions.
Reviews of previous research have highlighted the controversy surrounding the optimal timing of antibiotic initiation. That debate prompted the IDSA’s clarification.
Background research said that Kumar et al. reported a 7.6% increase in-hospital mortality for each hour of delay in the administration of effective antibiotics after septic shock onset.
The Infectious Diseases Society of America, founded in 1963, is a medical association representing physicians, scientists, and other health care professionals who specialize in infectious diseases. Based in Arlington, Virginia, it counted more than 13,000 members from across the United States and nearly 100 other countries on six continents as of 2023.
The Society grew out of two informal groups, one meeting each spring in Atlantic City, New Jersey, to discuss infectious disease topics, and another formed from the American Society for Microbiology’s antibiotics meetings; in October 1963 a planning committee met in Warrenton, Virginia, with 125 charter members and guests.
Beyond issuing clinical practice guidelines, the IDSA publishes the Journal of Infectious Diseases and Clinical Infectious Diseases, the latter being the journal in which the new clarification appears.
This new guidance specifically seeks to delineate the differences between generalized clinical recommendations and concrete strategies implemented at individual hospitals. Decision-making, it says, should be precise, based on local operational capacity and institutional protocols.